STOCK TITAN

DRRX 8-K: Announces Q2 2025 Financial Results Under Regulation FD

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DURECT Corporation disclosed that it announced its financial results for the quarter ended June 30, 2025 via a press release attached as Exhibit 99.1. The company filed this Current Report to distribute nonpublic information required by Regulation FD. The filing states that the financial information in the report and the exhibit shall not be deemed to be "filed" under Section 18 of the Exchange Act and will not be incorporated into registration statements except by specific reference. The 8-K itself does not include the underlying financial figures.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine earnings disclosure by 8-K; numbers are in the attached press release, so immediate financial assessment is not possible from this filing alone.

The filing notifies the market that DURECT announced results for the quarter ended June 30, 2025, but it includes no revenue, profit, cash, or guidance figures. For analysts and investors this means the 8-K signals a material event (an earnings release) but does not permit evaluation of performance until the press release (Exhibit 99.1) is reviewed. The filing's Regulation FD purpose indicates the company is formally disseminating previously nonpublic information.

TL;DR: Filing follows disclosure protocols under Regulation FD and includes standard legal language limiting "filing" status of the exhibit.

The 8-K explicitly states the attached financial information "shall not be deemed to be 'filed'" under Section 18 and will not be automatically incorporated into registration statements without specific reference. This is typical cautionary language that preserves liability distinctions for press releases and prevents inadvertent incorporation by reference. The document serves as formal distribution rather than a detailed financial disclosure within the 8-K itself.

false000108203800010820382025-08-122025-08-12

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

August 12, 2025

Date of Report

(Date of earliest event reported)

DURECT CORPORATION

(Exact name of Registrant as specified in its charter)

Delaware

 

000-31615

 

94-3297098

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

10240 Bubb Road

Cupertino, CA 95014

(Address of principal executive offices) (Zip code)

(408) 777-1417

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock $0.0001 par value per share
 

DRRX

The NASDAQ Stock Market LLC
(The Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 2.02. Results of Operations and Financial Condition.

On August 12, 2025, DURECT Corporation, a Delaware corporation (“DURECT”), announced its second quarter ended June 30, 2025 financial results. This Current Report is filed to disclose nonpublic information required to be disclosed by Regulation FD. A copy of DURECT’s press release is attached as Exhibit 99.1 hereto and incorporated by reference herein.

The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information concerning financial results in this Form 8-K and in Exhibit 99.1 shall not be incorporated into any registration statement or other document filed with the Securities and Exchange Commission by the company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

99.1

Press Release of DURECT Corporation dated August 12, 2025

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

DURECT Corporation

 

 

 

 

 

Date: August 12, 2025

 

By:

 

/s/ James E. Brown

 

 

 

 

    James E. Brown

    Chief Executive Officer

 

 

 

 

 

 

3


FAQ

What did DURECT (DRRX) disclose in this 8-K?

The company announced its financial results for the quarter ended June 30, 2025 and attached the related press release as Exhibit 99.1.

Are the financial figures included in the 8-K filing?

No. The 8-K states the press release contains the financial results; the filing itself does not include the underlying numbers.

Is the attached press release considered "filed" under Section 18?

No. The filing explicitly states that the financial information in the report and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act.

Why was this Current Report filed?

The company filed the report to disclose nonpublic information required to be disclosed by Regulation FD.

Where can I find the press release referenced in the 8-K?

The press release is attached to the Current Report as Exhibit 99.1.

DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.31M
27.26M
12.67%
23.58%
1.11%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO